- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Prospective, Multicentre
- Objective: To analyze the impact of three monoclonal antibody therapies on the genetic evolution of the S gene in high-risk COVID-19 patients by employing next-generation sequencing to detect viral population changes and minority variants emergence
- Number of participants enrolled: 264
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
External Links
Other information
Funders/Sponsors:
- French Ministry of Health Prevention
- French Ministry of Higher Education, Research and Innovation
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to